Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, announced today that the FDA has approved an Investigational Device Exemption ...
Al Jazeera2d
A ‘coup d’etat’: Israel’s Netanyahu pushes ahead with his judicial changes
After claiming in 2023 that the changes were ‘paused’, prime minister resurrects his plans to declaw the judiciary.